Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management explores innovative drug delivery systems utilizing nanotechnology to revolutionize the treatment and management of COPD. By presenting the latest advancements in nanotechnologies—including polymeric nanoparticles, liposomes, and theranostic nanoparticles—this volume aims to enhance patient outcomes, alleviate symptoms, and improve lung function, thereby addressing the urgent need for more effective therapies. Structured to cater to a diverse audience, from beginners to advanced researchers, this comprehensive text begins with an overview of COPD, its epidemiology, and current limitations in treatment. The core chapters explore a wide range of nanotechnological applications for diagnosis and disease management, including cutting-edge topics such as nano-immunotherapy and green nanotechnology. Each chapter was developed by a multidisciplinary team of experts from academia and industry, ensuring a comprehensive approach that integrates insights from pharmaceutical sciences, respiratory health, and bioinformatics. Nanotechnology-based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management not only fills a critical gap in COPD literature but also serves as an invaluable resource for researchers, clinicians, and students alike. It promises to be a definitive guide on how innovative drug delivery systems can transform COPD care, paving the way for future advancements in respiratory health management.
1. Chapter 1. Introduction to chronic obstructive pulmonary disease - p. 1 2. Chapter 2. Epidemiology and pathophysiology of COPD - p. 23 3. Chapter 3. Immunology and biomarkers of COPD - p. 41 4. Chapter 4. Nanotechnology-based diagnosis of COPD - p. 71 5. Chapter 5. Polymeric nanoparticles for the management of COPD - p. 87 6. Chapter 6. Solid lipid nanoparticles for the management of COPD - p. 117 7. Chapter 7. Metal and metal oxide nanoparticles for the management of COPD - p. 135 8. Chapter 8. Nanomicelles for the management of COPD - p. 165 9. Chapter 9. Liposomes for the management of COPD - p. 189 10. Chapter 10. Nanoemulsions for the management of COPD - p. 211 11. Chapter 11. Nanosuspensions for the management of COPD - p. 223 12. Chapter 12. Dendrimers for the management of COPD - p. 247 13. Chapter 13. Carbon nanotubes for the management of chronic obstructive pulmonary disease - p. 267 14. Chapter 14. Nanotechnology-based innovations in chronic obstructive pulmonary disease (COPD) treatment and management - p. 297 15. Chapter 15. Illuminating COPD therapy: Quantum dots as next-generation pulmonary nanomedicines - p. 317 16. Chapter 16. Theranostic nanoparticles for the management of COPD - p. 345 17. Chapter 17. Nano-immunotherapy for the management of COPD - p. 369 18. Chapter 18. Green nanotechnology for the management of chronic obstructive pulmonary disease: Concept, principle, prospectives and challenges - p. 411 19. Chapter 19. Regulatory requirements and clinical trials for nanotechnology-based drug delivery systems for the management of COPD - p. 443 20. Chapter 20. Challenges associated with nanotechnology and future directions in the management of COPD - p. 465 21. Index - p. 483
Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management explores innovative drug delivery systems utilizing nanotechnology to revolutionize the treatment and management of COPD. By presenting the latest advancements in nanotechnologies—including polymeric nanoparticles, liposomes, and theranostic nanoparticles—this volume aims to enhance patient outcomes, alleviate symptoms, and improve lung function, thereby addressing the urgent need for more effective therapies. Structured to cater to a diverse audience, from beginners to advanced researchers, this comprehensive text begins with an overview of COPD, its epidemiology, and current limitations in treatment. The core chapters explore a wide range of nanotechnological applications for diagnosis and disease management, including cutting-edge topics such as nano-immunotherapy and green nanotechnology. Each chapter was developed by a multidisciplinary team of experts from academia and industry, ensuring a comprehensive approach that integrates insights from pharmaceutical sciences, respiratory health, and bioinformatics. Nanotechnology-based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management not only fills a critical gap in COPD literature but also serves as an invaluable resource for researchers, clinicians, and students alike. It promises to be a definitive guide on how innovative drug delivery systems can transform COPD care, paving the way for future advancements in respiratory health management.
1. Chapter 1. Introduction to chronic obstructive pulmonary disease - p. 1 2. Chapter 2. Epidemiology and pathophysiology of COPD - p. 23 3. Chapter 3. Immunology and biomarkers of COPD - p. 41 4. Chapter 4. Nanotechnology-based diagnosis of COPD - p. 71 5. Chapter 5. Polymeric nanoparticles for the management of COPD - p. 87 6. Chapter 6. Solid lipid nanoparticles for the management of COPD - p. 117 7. Chapter 7. Metal and metal oxide nanoparticles for the management of COPD - p. 135 8. Chapter 8. Nanomicelles for the management of COPD - p. 165 9. Chapter 9. Liposomes for the management of COPD - p. 189 10. Chapter 10. Nanoemulsions for the management of COPD - p. 211 11. Chapter 11. Nanosuspensions for the management of COPD - p. 223 12. Chapter 12. Dendrimers for the management of COPD - p. 247 13. Chapter 13. Carbon nanotubes for the management of chronic obstructive pulmonary disease - p. 267 14. Chapter 14. Nanotechnology-based innovations in chronic obstructive pulmonary disease (COPD) treatment and management - p. 297 15. Chapter 15. Illuminating COPD therapy: Quantum dots as next-generation pulmonary nanomedicines - p. 317 16. Chapter 16. Theranostic nanoparticles for the management of COPD - p. 345 17. Chapter 17. Nano-immunotherapy for the management of COPD - p. 369 18. Chapter 18. Green nanotechnology for the management of chronic obstructive pulmonary disease: Concept, principle, prospectives and challenges - p. 411 19. Chapter 19. Regulatory requirements and clinical trials for nanotechnology-based drug delivery systems for the management of COPD - p. 443 20. Chapter 20. Challenges associated with nanotechnology and future directions in the management of COPD - p. 465 21. Index - p. 483
